hydroxyurea has been researched along with B-Cell Chronic Lymphocytic Leukemia in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association of chronic lymphocytic leukemia (CLL) with essential thrombocythemia (ET) is an extremely rare event and until now 3 patients with such coexistence have been reported in the literature." | 2.42 | Coexistence of chronic lymphocytic leukemia and essential thrombocythemia. ( Bartkowiak, J; Góra-Tybor, J; Kordek, R; Korycka, A; Polliack, A; Robak, T; Urbańska-Ryś, H; Wawrzyniak, E, 2003) |
| "Its use in the treatment of essential thrombocythemia began later in 1950." | 2.41 | Treatment of the myeloproliferative disorders with 32P. ( Berlin, NI, 2000) |
| "Fludarabine phosphate (2-F-ara-AMP) is an adenine nucleoside analogue that shows significant activity against chronic lymphocytic leukemia and indolent lymphoma." | 1.31 | In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis. ( Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robak, T | 1 |
| Urbańska-Ryś, H | 1 |
| Góra-Tybor, J | 1 |
| Wawrzyniak, E | 1 |
| Korycka, A | 1 |
| Bartkowiak, J | 1 |
| Kordek, R | 1 |
| Polliack, A | 1 |
| Henry, L | 1 |
| Carillo, S | 1 |
| Jourdan, E | 1 |
| Arnaud, A | 1 |
| Brun, S | 1 |
| Lavabre-Bertrand, T | 1 |
| Akansel, G | 1 |
| Liu, Y | 1 |
| Chitambar, CR | 1 |
| Kitapci, MT | 1 |
| Akansel, S | 1 |
| Krasnow, AZ | 1 |
| Isitman, AT | 1 |
| Collier, BD | 1 |
| Kano, Y | 1 |
| Akutsu, M | 1 |
| Tsunoda, S | 1 |
| Suzuki, K | 1 |
| Ichikawa, A | 1 |
| Furukawa, Y | 1 |
| Bai, L | 1 |
| Kon, K | 1 |
| Berlin, NI | 1 |
| Van Den Neste, E | 1 |
| Cardoen, S | 1 |
| Husson, B | 1 |
| Rosier, JF | 1 |
| Delacauw, A | 1 |
| Ferrant, A | 1 |
| Van den Berghe, G | 1 |
| Bontemps, F | 1 |
| Gandhi, V | 1 |
| Kemena, A | 1 |
| Keating, MJ | 1 |
| Plunkett, W | 1 |
2 reviews available for hydroxyurea and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Coexistence of chronic lymphocytic leukemia and essential thrombocythemia.
Topics: Aged; Chromosome Deletion; Chromosomes, Human, Pair 13; Clone Cells; Cytogenetic Analysis; Diagnosis | 2003 |
Treatment of the myeloproliferative disorders with 32P.
Topics: Adult; Aged; Alkylating Agents; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; D | 2000 |
5 other studies available for hydroxyurea and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.
Topics: Female; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoprolifera | 2007 |
Effect of gallium nitrate therapy on Ga-67 scintigraphic detection of lymphoma: case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium; Galliu | 1997 |
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; | 2000 |
2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
Topics: Alkylating Agents; Alkylation; Antimetabolites, Antineoplastic; Apoptosis; B-Lymphocytes; Caspase 3; | 2002 |
Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Synergism; F | 1992 |